←
Ed Esplin, MD, PhD2,846 posts
Ed Esplin, MD, PhD avatar

Ed Esplin, MD, PhD

@EdEsplin

Clinical Geneticist FACMG CGAF FACP | SVP Med Affairs @Biocartis | Founder @ Stealth Startup | Med. Officer @Invitae (exit) | @UTSWMedCenter @UUtah posts own

◷ Joined November 2018▧ 403 Photos and videos
Ed Esplin, MD, PhD avatar
Ed Esplin, MD, PhD@EdEsplin·Nov 7

#HuBMAP Data Portal: a resource for #multimodal #spatial & #singlecell data of healthy human tissues The NIH Human BioMolecular Atlas Program (#HuBMAP) Data Portal (portal.hubmapconsortium.org/) 9,316 public datasets 26 data types 29 organ classes Including #largeintestine/#colon & #smallintestine/#smallbowel led by @Stanford #HuBMAP #TissueMappingCenter/#TMC @TheSnyderLab nature.com/articles/s41467-0… #MorganTurner et al @_hubmap @NatureComms

Post attachmentPost attachmentPost attachmentPost attachment
CGA-IGC avatar
⟳ Ed Esplin, MD, PhD retweeted
CGA-IGC@CGAIGC·Nov 5

🏆 Maureen Mork from @UTMDAnderson was not only the very deserving recipient of the 2026 Dennis J. Ahnen Outstanding Service Award at #CGAIGC26, but also delivered an insightful presentation on an important topic, "Novel Approaches to Genetic Testing." Ms Mork shared insights into the ongoing challenge of low cascade genetic testing uptake among at-risk relatives and explored potential strategies to improve participation. 🔹 Innovative approaches include patient navigation, reducing financial barriers, and at-home genetic testing. 🔹 No single intervention has consistently achieved the desired results, highlighting the need for creative, multimodal approaches to improve testing uptake. 🎥 Watch this short interview 👇to hear Ms Mork's key takeaways and what they mean for the multidisciplinary #hereditarygicancer care team. #CascadeTesting #GeneticCounseling

1:29
CGA-IGC avatar
⟳ Ed Esplin, MD, PhD retweeted
CGA-IGC@CGAIGC·Nov 4

📣We're excited to kick off #PancreaticCancerAwarenessMonth & sharing exciting advances in pancreatic cancer treatment! At #CGAIGC26, Dr. Lindsay Davis, a medical oncologist from the @CUCancerCenter highlights emerging treatment options, including PARP inhibitors, immunotherapy, & promising new KRAS-targeted therapies. With KRAS mutations found in approximately 93% of pancreatic cancers, these developments offer new hope for more personalized treatment approaches & improved patient outcomes. 📽️Watch this short sound bite 👇 to hear Dr. Davis share the latest developments & what they could mean for patients!

2:44
CGA-IGC avatar
⟳ Ed Esplin, MD, PhD retweeted
CGA-IGC@CGAIGC·Nov 4

🎥 Does AI-assisted colonoscopy improve lesion detection in patients with #LynchSsyndrome? At #CGAIGC26, @RHuneburg from University Hospital Bonn, Germany, shares findings from the CADLY-2 trial, published in The Lancet Gastroenterology & Hepatology Watch this short video 👇 to hear the key findings and their implications for Lynch syndrome surveillance. #hereditarygicancer

0:42
CGA-IGC avatar
⟳ Ed Esplin, MD, PhD retweeted
CGA-IGC@CGAIGC·Nov 3

🎥 Missed the Randall Burt Lecture at #CGAIGC26 or couldn't join us in Denver? 🙏to our Communications Committee member Benjamin Lerner, MD who caught up with James Ford, MD following his Randall Burt Lecture, “A Pre-Cancer Atlas for Hereditary Colorectal Cancer: Using FAP as a Model System.” 🧬 In this insightful interview, Dr. Ford shares insights into how familial adenomatous polyposis (FAP) can serve as a model for understanding the earliest stages of colorectal cancer development and the potential implications for future cancer prevention strategies. 🎧 Take a few minutes to listen to this fascinating conversation and hear directly from Dr. Ford! #HereditaryGICancer #CancerResearch @MSpringerGC @EdEsplin @asaf_maoz @HHampel1 @AparajitaSingh0

5:10
CGA-IGC avatar
⟳ Ed Esplin, MD, PhD retweeted
CGA-IGC@CGAIGC·Nov 2

Dr. James Ford delivers the Randall Burt Lecture, “A Pre-Cancer Atlas for Hereditary Colorectal Cancer: Using FAP as a Model System.” #CGAIGC26

Post attachment